yacine abed - Infectious Diseases

Author Information

Dr. Yacine Abed is affiliated with the Research Center in Infectious Diseases of the CHU of Québec and Laval University, located in Québec City, Canada. Dr. Abed's work is primarily focused on the study of influenza viruses and their resistance to antiviral treatments, a field of significant importance in infectious diseases research.

Research Contributions

Dr. Yacine Abed has made substantial contributions to the field of infectious diseases, with a particular emphasis on influenza virus research. His work explores the replication, transmission, and drug resistance of influenza A and B viruses. Noteworthy topics in his research include the fitness of influenza viruses with reduced susceptibility to antiviral drugs like baloxavir, the molecular pathways of pan-neuraminidase inhibitor resistance, and the effects of drug combinations in treating influenza infections. His research findings are crucial for understanding and addressing drug resistance in influenza viruses, which is vital for developing effective treatments and managing outbreaks.

Aliases

There are no aliases mentioned for Dr. Yacine Abed in the provided information.

Publication and Citation Metrics

Metric	Value
Total Papers	97
Citation Count	5529
H-index	41

Publications:

Replication and transmission of an influenza A(H3N2) virus harboring the polymerase acidic I38T substitution, in guinea pigs.

DOI: 10.1099/jgv.0.001659

Year: 2021

Fitness of influenza A and B viruses with reduced susceptibility to baloxavir: A mini‐review

DOI: 10.1002/rmv.2175

Year: 2020

Effects of Different Drug Combinations in Immunodeficient Mice Infected with an Influenza A/H3N2 Virus

DOI: 10.3390/microorganisms8121968

Year: 2020

Molecular Pathway of Influenza Pan-neuraminidase Inhibitor Resistance in an Immunocompromised Patient

DOI: 10.3851/IMP3344

Year: 2020

Characterization of contemporary influenza B recombinant viruses harboring mutations of reduced susceptibility to baloxavir marboxil, in vitro and in mice.

DOI: 10.1016/j.antiviral.2020.104807

Year: 2020

In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses

DOI: 10.3390/v12101139

Year: 2020

Molecular pathway of influenza pan-neuraminidase inhibitors resistance in an immunocompromised patient

DOI: 10.1101/768614

Year: 2019

The Val430Ile neuraminidase (NA) substitution, identified in influenza B virus isolates, impacts the catalytic 116Arg residue causing reduced susceptibility to NA inhibitors.

DOI: 10.1016/j.antiviral.2019.104561

Year: 2019

Synergistic PA and HA mutations confer mouse adaptation of a contemporary A/H3N2 influenza virus

DOI: 10.1038/s41598-019-51877-4

Year: 2019

Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada

DOI: 10.3201/eid2504.181554

Year: 2019

What is respiratory hygiene and why is it important?

What are Quarantine and Isolation?

What are the Best Practices for Food Hygiene?

What are Vaccines?

What is Immunotherapy?

What are the Treatments for Zika Virus?

What About Monogamy and Antibiotic Resistance?

How Often Should You Get a Health Check-Up?

How to Use Antibiotics Responsibly?

How is Safety Assessed?

Partnered Content Networks

Relevant Topics